These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 20526846

  • 21. Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China.
    Ge SH, Wan Z, Li J, Xu J, Li RY, Bai FY.
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3126-31. PubMed ID: 20516286
    [Abstract] [Full Text] [Related]

  • 22. Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates.
    Fattouh N, Hdayed D, Geukgeuzian G, Tokajian S, Khalaf RA.
    Fungal Genet Biol; 2021 Aug; 153():103575. PubMed ID: 34033880
    [Abstract] [Full Text] [Related]

  • 23. Overexpression and mutation as a genetic mechanism of fluconazole resistance in Candida albicans isolated from human immunodeficiency virus patients in Indonesia.
    Rosana Y, Yasmon A, Lestari DC.
    J Med Microbiol; 2015 Sep; 64(9):1046-1052. PubMed ID: 26297039
    [Abstract] [Full Text] [Related]

  • 24. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.
    Dunkel N, Liu TT, Barker KS, Homayouni R, Morschhäuser J, Rogers PD.
    Eukaryot Cell; 2008 Jul; 7(7):1180-90. PubMed ID: 18487346
    [Abstract] [Full Text] [Related]

  • 25. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D, Coste AT.
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [Abstract] [Full Text] [Related]

  • 26. Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India.
    Singh A, Singh PK, de Groot T, Kumar A, Mathur P, Tarai B, Sachdeva N, Upadhyaya G, Sarma S, Meis JF, Chowdhary A.
    J Antimicrob Chemother; 2019 May 01; 74(5):1260-1268. PubMed ID: 30753525
    [Abstract] [Full Text] [Related]

  • 27. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
    Sanglard D, Ischer F, Koymans L, Bille J.
    Antimicrob Agents Chemother; 1998 Feb 01; 42(2):241-53. PubMed ID: 9527767
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China.
    Liu JY, Shi C, Wang Y, Li WJ, Zhao Y, Xiang MJ.
    Res Microbiol; 2015 Apr 01; 166(3):153-61. PubMed ID: 25748216
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Aspergillus fumigatus Intrinsic Fluconazole Resistance Is Due to the Naturally Occurring T301I Substitution in Cyp51Ap.
    Leonardelli F, Macedo D, Dudiuk C, Cabeza MS, Gamarra S, Garcia-Effron G.
    Antimicrob Agents Chemother; 2016 Sep 01; 60(9):5420-6. PubMed ID: 27381395
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.